Khondrion
PrivateLast Round
VC Round
May 6, 2025
Total Funding Raised
$3.82M
Company Overview
Khondrion operates in Healthcare & Life Sciences and is based in Nijmegen. Its latest recorded funding round was a VC Round in May 2025.
Khondrion is a clinical-stage biopharmaceutical company discovering and developing therapies targeting primary mitochondrial disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Khondrion Comparables
Compare Khondrion with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OMEICOS Therapeutics | 86% | |
| Morningside | 84% | |
| Tisento Therapeutics | 83% |
For institutional investors. Book with your work email.
Khondrion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 6, 2025 | ||||
| VC Round | Nov 21, 2024 | ||||
| Grant | Jul 31, 2018 | ||||
| Grant | Sep 12, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Khondrion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| European Innovation Council Fund | Grant |
| Ride4Kids | VC Round |
| The Total Innovation Management Foundation | VC Round |
| United Mitochondrial Disease Foundation | VC Round |
| Stichting Join4Energy | VC Round |
| European Regional Development Fund | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2026
Grew 33% QoQ from 9 to 12 employees.
- Dec 24, 2025
Grew 100% QoQ from 6 to 12 employees.
For institutional investors. Book with your work email.
Khondrion Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Khondrion's valuation, stock price, and market status.
Is Khondrion a public or private company?
Khondrion is a private company.
What is the current stock price of Khondrion?
Khondrion is a private company, so its shares have no public market price. Caplight tracks Khondrion's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Khondrion worth (valuation)?
Valuation information for Khondrion is not publicly available.
Can I buy Khondrion stock?
Khondrion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Khondrion's last funding round?
Khondrion's most recent funding round was VC Round on May 6, 2025.
Who are the main investors in Khondrion?
Key investors in Khondrion include United Mitochondrial Disease Foundation, Netherlands Enterprise Agency.
Will Khondrion IPO soon?
No public IPO plans have been announced for Khondrion.
How can I track Khondrion secondary market activity?
Caplight tracks bids, offers, and trades in Khondrion's shares on secondary markets.